Glenmede Trust’s ARK Genomic Revolution ETF ARKG Stock Holding History

Glenmede Trust’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-465	Closed	-$21K	–	1288
2022 Q1	$21K	Sell	465 -56	-11%	-$2.67K	﹤0.01%	1266
2021 Q4	$31K	Buy	521 +100	+24%	+$6.91K	﹤0.01%	1259
2021 Q3	$31K	Buy	421 +25	+6%	+$2.1K	﹤0.01%	1227
2021 Q2	$36K	Hold	396	–	–	﹤0.01%	1215
2021 Q1	$34K	Hold	396	–	–	﹤0.01%	1136
2020 Q4	$36K	Buy	+396	New	+$31.6K	﹤0.01%	1137

Other funds holding ARKG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

Glenmede Trust's ARKG Position: Q2 2022 in Review

Glenmede Trust sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2022, closing a stake of 465 shares — an estimated $21K sold.

Glenmede Trust first reported a position in ARKG in Q4 2020 and held it in 6 quarters. The position peaked at $36K in Q2 2021. 333 funds tracked by Wall St. Rank hold ARKG as of Q2 2022.

Glenmede Trust reported no remaining ARK Genomic Revolution ETF position as of Q2 2022 after selling out during the quarter.
Glenmede Trust sold 465 ARK Genomic Revolution ETF shares in Q2 2022, an estimated $21K.
Glenmede Trust first reported a position in ARK Genomic Revolution ETF in Q4 2020 and held it in 6 quarters.
Glenmede Trust's ARK Genomic Revolution ETF position peaked at $36K in Q2 2021.
333 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2022.

Based on Glenmede Trust's 13F filing for Q2 2022, filed 15 Aug 2022.